217 related articles for article (PubMed ID: 34297745)
1. Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination.
Biswas A; Zhou D; Fiches GN; Wu Z; Liu X; Ma Q; Zhao W; Zhu J; Santoso NG
PLoS Pathog; 2021 Jul; 17(7):e1009764. PubMed ID: 34297745
[TBL] [Abstract][Full Text] [Related]
2. STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.
King CA; Li X; Barbachano-Guerrero A; Bhaduri-McIntosh S
J Virol; 2015 Nov; 89(22):11347-55. PubMed ID: 26339061
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Polo-like kinase 1 (PLK1) facilitates the elimination of HIV-1 viral reservoirs in CD4
Zhou D; Hayashi T; Jean M; Kong W; Fiches G; Biswas A; Liu S; Yosief HO; Zhang X; Bradner J; Qi J; Zhang W; Santoso N; Zhu J
Sci Adv; 2020 Jul; 6(29):eaba1941. PubMed ID: 32832623
[TBL] [Abstract][Full Text] [Related]
4. KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA.
Cheng F; Weidner-Glunde M; Varjosalo M; Rainio EM; Lehtonen A; Schulz TF; Koskinen PJ; Taipale J; Ojala PM
PLoS Pathog; 2009 Mar; 5(3):e1000324. PubMed ID: 19266083
[TBL] [Abstract][Full Text] [Related]
5. Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.
Li Q; He M; Zhou F; Ye F; Gao SJ
J Virol; 2014 Jun; 88(11):6355-67. PubMed ID: 24672028
[TBL] [Abstract][Full Text] [Related]
6. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
Smith CG; Kharkwal H; Wilson DW
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
[TBL] [Abstract][Full Text] [Related]
7. KRAB-ZFP Repressors Enforce Quiescence of Oncogenic Human Herpesviruses.
Li X; Burton EM; Koganti S; Zhi J; Doyle F; Tenenbaum SA; Horn B; Bhaduri-McIntosh S
J Virol; 2018 Jul; 92(14):. PubMed ID: 29695433
[TBL] [Abstract][Full Text] [Related]
8. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma.
Jiang Y; Xu D; Zhao Y; Zhang L
PLoS One; 2008 Feb; 3(2):e1569. PubMed ID: 18253508
[TBL] [Abstract][Full Text] [Related]
9. EBV and KSHV Infection Dysregulates Autophagy to Optimize Viral Replication, Prevent Immune Recognition and Promote Tumorigenesis.
Cirone M
Viruses; 2018 Oct; 10(11):. PubMed ID: 30384495
[TBL] [Abstract][Full Text] [Related]
10. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
Ye J; Gradoville L; Daigle D; Miller G
J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
Purushothaman P; Thakker S; Verma SC
J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor signaling controls reactivation of KSHV from latency.
Gregory SM; West JA; Dillon PJ; Hilscher C; Dittmer DP; Damania B
Proc Natl Acad Sci U S A; 2009 Jul; 106(28):11725-30. PubMed ID: 19564611
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle.
Sadagopan S; Valiya Veettil M; Paudel N; Bottero V; Chandran B
J Virol; 2011 Mar; 85(6):2666-85. PubMed ID: 21209106
[TBL] [Abstract][Full Text] [Related]
14. Myc is required for the maintenance of Kaposi's sarcoma-associated herpesvirus latency.
Li X; Chen S; Feng J; Deng H; Sun R
J Virol; 2010 Sep; 84(17):8945-8. PubMed ID: 20573831
[TBL] [Abstract][Full Text] [Related]
15. Targeting FoxO proteins induces lytic reactivation of KSHV for treating herpesviral primary effusion lymphoma.
Lan J; Wang Y; Yue S; Xu D; Li Y; Peng X; Hu J; Ju E; He S; Li T
PLoS Pathog; 2023 Aug; 19(8):e1011581. PubMed ID: 37594999
[TBL] [Abstract][Full Text] [Related]
16. Nonsense-mediated decay controls the reactivation of the oncogenic herpesviruses EBV and KSHV.
van Gent M; Reich A; Velu SE; Gack MU
PLoS Biol; 2021 Feb; 19(2):e3001097. PubMed ID: 33596193
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus (EBV) Rta-mediated EBV and Kaposi's sarcoma-associated herpesvirus lytic reactivations in 293 cells.
Chen YJ; Tsai WH; Chen YL; Ko YC; Chou SP; Chen JY; Lin SF
PLoS One; 2011 Mar; 6(3):e17809. PubMed ID: 21423768
[TBL] [Abstract][Full Text] [Related]
18. Bone Marrow-Derived SH-SY5Y Neuroblastoma Cells Infected with Kaposi's Sarcoma-Associated Herpesvirus Display Unique Infection Phenotypes and Growth Properties.
Kong X; Li D; Mansouri A; Kang G; Sayood K; West J; Wood C
J Virol; 2021 Jun; 95(13):e0000321. PubMed ID: 33853962
[TBL] [Abstract][Full Text] [Related]
19. Cdk1 inhibition induces mutually inhibitory apoptosis and reactivation of Kaposi's sarcoma-associated herpesvirus.
Li X; Chen S; Sun R
J Virol; 2012 Jun; 86(12):6668-76. PubMed ID: 22496227
[TBL] [Abstract][Full Text] [Related]
20. Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication Is Independent of Anaphase-Promoting Complex Activity.
Elbasani E; Gramolelli S; GĂŒnther T; Gabaev I; Grundhoff A; Ojala PM
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
